Controlled-release injectable peptide platform evaluated in preclinical study 2026 Announcements . Clinical . News 12.01.2026
SCENESSE® efficacy in vitiligo: new cases presented at RDTC Conference 2026 Announcements . Clinical . News 08.01.2026
Notification of cessation of securities 2026 Announcements . Financial . News . Regulatory 02.01.2026